Effect of Patient Socioeconomic Status and Body Mass Index on the Quality of Breast Cancer Adjuvant Chemotherapy

Author:

Griggs Jennifer J.1,Culakova Eva1,Sorbero Melony E.S.1,van Ryn Michelle1,Poniewierski Marek S.1,Wolff Debra A.1,Crawford Jeffrey1,Dale David C.1,Lyman Gary H.1

Affiliation:

1. From the Department of Medicine, University of Rochester, Rochester, NY; RAND Corporation, Pittsburgh, PA; University of Washington, Seattle, WA; Duke Comprehensive Cancer Center and the Department of Medicine, Duke University, Durham, NC

Abstract

Purpose The purpose of this study was to investigate the relationship between socioeconomic status (SES) and the use of intentionally reduced doses of chemotherapy in the adjuvant treatment of breast cancer. Patients and Methods Patients with breast cancer treated with a standard chemotherapy regimen (n = 764) were enrolled in a prospective registry after signing informed consent. Detailed information was collected on patient, disease, and treatment, including chemotherapy doses. Zip code level data on median household income, proportion of people living below the poverty level, and educational attainment were obtained from the US Census. Doses for the first cycle of chemotherapy lower than 85% of standard were considered to be reduced. Univariate analyses and multivariate logistic regression were performed to identify factors associated with the use of reduced first cycle doses. Results In univariate analysis, individual education attainment, zip code SES measures, body mass index, and geographic region were all significantly associated with receipt of intentionally reduced doses of chemotherapy. In multivariate analysis, controlling for geography, factors independently associated with reduced doses were obesity (odds ratio [OR], 2.47; 95% CI, 1.36 to 4.51), severe obesity (OR, 4.04; 95% CI, 1.46 to 11.19), and education less than high school (OR, 3.07; 95% CI, 1.57 to 5.99). Conclusion Social disparities in breast cancer outcomes may be in part the result of lower quality chemotherapy doses in the adjuvant treatment of breast cancer. Efforts to address such prescribing patterns may help reduce SES disparities in breast cancer survival.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Reference68 articles.

1. Survival of Breast Cancer Patients in Connecticut in Relation to Socioeconomic and Health Care Access Indicators

2. Kogevinas M, Porta M: Socioeconomic differences in cancer survival: A review of the evidence. IARC Sci Publ 138:177,1997-206,

3. Auvinen A, Karjalainen S: Possible explanations for social class differences in cancer patient survival. IARC Sci Publ 138:377,1997-397,

4. Race, Socioeconomic Status, and Breast Cancer Treatment and Survival

5. Reynolds P, Boyd PT, Blacklow RS, et al: The relationship between social ties and survival among black and white breast cancer patients: National Cancer Institute Black/White Cancer Survival Study Group. Cancer Epidemiol Biomarkers Prev 3:253,1994-259,

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3